Published in Int J Cancer on October 15, 2007
Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Res (2011) 0.98
Prostate cancer-associated gene expression alterations determined from needle biopsies. Clin Cancer Res (2009) 0.83
Id1 delays senescence of primary human melanocytes. Mol Carcinog (2008) 0.82
Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia. Int J Clin Exp Pathol (2015) 0.77
Id1 overexpression is independent of repression and epigenetic silencing of tumor suppressor genes in melanoma. Epigenetics (2010) 0.76
Id Proteins Contribute to Tumor Development and Metastatic Colonization in a Model of Bladder Carcinogenesis. Bladder Cancer (2015) 0.75
Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36
Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res (2008) 3.67
Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol (2010) 3.38
Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One (2007) 2.77
Modeling precision treatment of breast cancer. Genome Biol (2013) 2.42
Id proteins in cell growth and tumorigenesis. Cancer Cell (2003) 2.38
Toward a molecular classification of melanoma. J Clin Oncol (2007) 1.95
Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. Am J Kidney Dis (2005) 1.69
Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort. Cancer Biol Ther (2011) 1.62
Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol Cell Biol (2005) 1.52
Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell (2002) 1.42
Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin Cancer Res (2004) 1.35
Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP. Proc Natl Acad Sci U S A (2011) 1.30
LKB1 protein expression in human breast cancer. Appl Immunohistochem Mol Morphol (2006) 1.28
Hypermethylation in histologically distinct classes of breast cancer. Clin Cancer Res (2004) 1.25
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. J Clin Oncol (2014) 1.23
Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. Cancer Biol Ther (2006) 1.19
Synthesis and evaluation of a potent and selective cell-permeable p300 histone acetyltransferase inhibitor. J Am Chem Soc (2005) 1.14
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell (2013) 1.14
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer. Cancer Res (2010) 1.13
Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res (2004) 1.10
Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell (2003) 1.08
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131. Neuro Oncol (2008) 1.06
Melanoma biomarkers: current status and vision for the future. Nat Clin Pract Oncol (2008) 1.05
MC1R is a potent regulator of PTEN after UV exposure in melanocytes. Mol Cell (2013) 1.05
High calorie diet triggers hypothalamic angiopathy. Mol Metab (2012) 1.01
A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype. Carcinogenesis (2012) 1.01
Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Res (2011) 0.98
Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls. Breast Cancer Res (2007) 0.96
Southern Rural Access Program: an overview. J Rural Health (2003) 0.96
Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells. J Invest Dermatol (2013) 0.96
Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis. Cancer Biol Ther (2008) 0.93
Methylation profiling of benign and malignant breast lesions and its application to cytopathology. Mod Pathol (2003) 0.93
Two-color quantitative multiplex methylation-specific PCR. Biotechniques (2006) 0.92
Selective HAT inhibitors as mechanistic tools for protein acetylation. Methods Enzymol (2004) 0.91
A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women. Cancer Biol Ther (2007) 0.90
Basal-like breast cancer displays distinct patterns of promoter methylation. Cancer Biol Ther (2010) 0.90
Id1 promotes tumor cell migration in nonsmall cell lung cancers. J Oncol (2010) 0.88
Dermatomyositis: a clinicopathological study of 40 patients. Am J Dermatopathol (2009) 0.88
Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events. Clin Chim Acta (2013) 0.87
Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women. Gynecol Oncol (2010) 0.86
Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1. Cancer Cell (2003) 0.85
BRAF kinase in melanoma development and progression. Expert Rev Mol Med (2008) 0.85
Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction. Cancer Res (2011) 0.84
High-efficiency stable gene transduction in primary human melanocytes using a lentiviral expression system. J Invest Dermatol (2004) 0.84
DNA repair gene variants in relation to overall cancer risk: a population-based study. Carcinogenesis (2012) 0.84
Neuropilin-2: a novel biomarker for malignant melanoma? Hum Pathol (2011) 0.83
Global analysis of BRAFV600E target genes in human melanocytes identifies matrix metalloproteinase-1 as a critical mediator of melanoma growth. J Invest Dermatol (2011) 0.83
Cigarette smoking and malignant melanoma: a case-control study. J Am Acad Dermatol (2010) 0.82
Id1 delays senescence of primary human melanocytes. Mol Carcinog (2008) 0.82
A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer. Cancer Epidemiol (2012) 0.82
The association between skin characteristics and skin cancer prevention behaviors. Cancer Epidemiol Biomarkers Prev (2009) 0.82
DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cells. Oncotarget (2013) 0.82
MicroRNAs as an emerging target for melanoma therapy. J Invest Dermatol (2013) 0.81
A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer. J Invest Dermatol (2012) 0.81
Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Virchows Arch (2010) 0.80
Mode of action associated with development of hemangiosarcoma in mice given pregabalin and assessment of human relevance. Toxicol Sci (2012) 0.80
Monitoring methylation and gene expression in cancer. Methods Mol Biol (2007) 0.78
Notch signaling mediates melanoma-endothelial cell communication and melanoma cell migration. Pigment Cell Melanoma Res (2013) 0.78
Glyceraldehyde-3-phosphate dehydrogenase expression is altered by hypoxia in melanoma cells and primary human melanocytes. Melanoma Res (2010) 0.77
Prognostic factors of overall survival for patients with stage II colon cancer. Acta Med Acad (2014) 0.77
Hemangiosarcoma in mice administered pregabalin: analysis of genotoxicity, tumor incidence, and tumor genetics. Toxicol Sci (2012) 0.76
A Rare Case of Immune Reconstitution Inflammatory Syndrome Development in an Immunocompromised Patient with Progressive Multifocal Leukoencephalopathy and Multicentric Castleman's Disease. Case Rep Neurol Med (2013) 0.75
A simple engineered platform reveals different modes of tumor-microenvironmental cell interaction. Biofabrication (2015) 0.75
Control of Spatial Attention by the Primate Superior Colliculus. J Vis (2015) 0.75
Renal artery pseudoaneurysm resulting from blunt trauma. Am Surg (2012) 0.75
The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research. Cancer Prev Res (Phila) (2011) 0.75
Neuropilin-2 promotes melanoma growth and progression in vivo. Melanoma Res (2016) 0.75
Assessing the value of children's asthma camps. J Asthma (2006) 0.75